The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis

被引：0
|
作者：
Huy Gia Vuong
Thu Quynh Nguyen
Tam N. M. Ngo
Hoang Cong Nguyen
Kar-Ming Fung
Ian F. Dunn
机构：
[1] Oklahoma University Health Sciences Center,Department of Pathology
[2] Oklahoma University Health Sciences Center,Stephenson Cancer Center
[3] Pham Ngoc Thach University of Medicine,Faculty of Medicine
[4] Oklahoma University Health Sciences Center,Department of Neurosurgery
来源：
BMC Cancer | / 20卷
关键词：
Glioma; Glioblastoma; TERT; MGMT; Temozolomide; Overall survival; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis
    Qiao, Baoli
    Zhang, Zhenyu
    Li, Yanfang
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2018, 6 (01): : 69 - 76
  • [32] A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
    Hideyuki Arita
    Kai Yamasaki
    Yuko Matsushita
    Taishi Nakamura
    Asanao Shimokawa
    Hirokazu Takami
    Shota Tanaka
    Akitake Mukasa
    Mitsuaki Shirahata
    Saki Shimizu
    Kaori Suzuki
    Kuniaki Saito
    Keiichi Kobayashi
    Fumi Higuchi
    Takeo Uzuka
    Ryohei Otani
    Kaoru Tamura
    Kazutaka Sumita
    Makoto Ohno
    Yasuji Miyakita
    Naoki Kagawa
    Naoya Hashimoto
    Ryusuke Hatae
    Koji Yoshimoto
    Naoki Shinojima
    Hideo Nakamura
    Yonehiro Kanemura
    Yoshiko Okita
    Manabu Kinoshita
    Kenichi Ishibashi
    Tomoko Shofuda
    Yoshinori Kodama
    Kanji Mori
    Yusuke Tomogane
    Junya Fukai
    Koji Fujita
    Yuzo Terakawa
    Naohiro Tsuyuguchi
    Shusuke Moriuchi
    Masahiro Nonaka
    Hiroyoshi Suzuki
    Makoto Shibuya
    Taketoshi Maehara
    Nobuhito Saito
    Motoo Nagane
    Nobutaka Kawahara
    Keisuke Ueki
    Toshiki Yoshimine
    Etsuo Miyaoka
    Ryo Nishikawa
    Acta Neuropathologica Communications, 4
  • [33] The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival
    Shu, Chang
    Wang, Qiong
    Yan, Xiaoling
    Wang, Jinhuan
    CANCER MEDICINE, 2018, 7 (08): : 3704 - 3712
  • [34] Prognosis value of MGMT promoter methylation for patients with lung cancer: a meta-analysis (vol 8, pg 11560, 2015)
    Chen, Chao
    Hua, Haiqing
    Han, Chenglong
    Cheng, Yuan
    Cheng, Yin
    Wang, Zhen
    Bao, Jutao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 2752 - 2752
  • [35] Promoter methylation of MGMT in oral carcinoma: A population-based study and meta-analysis
    Jayaprakash, Chinchu
    Radhakrishnan, Raghu
    Ray, Satadru
    Satyamoorthy, Kapaettu
    ARCHIVES OF ORAL BIOLOGY, 2017, 80 : 197 - 208
  • [36] TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis
    Hewer, Ekkehard
    Phour, Jaison
    Gutt-Will, Marielena
    Schucht, Philippe
    Dettmer, Matthias S.
    Vassella, Erik
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (04): : 430 - 436
  • [37] Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies
    Zhao, Jia-Jun
    Li, Hong-Yu
    Wang, Di
    Yao, Hui
    Sun, Da-Wei
    TUMOR BIOLOGY, 2014, 35 (10) : 10085 - 10093
  • [38] Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy
    Nguyen, HuyTram N.
    Lie, Amy
    Li, Tie
    Chowdhury, Reshmi
    Liu, Fei
    Ozer, Byram
    Wei, Bowen
    Green, Richard M.
    Ellingson, Benjamin M.
    Wang, He-jing
    Elashoff, Robert
    Liau, Linda M.
    Yong, William H.
    Nghiemphu, Phioanh L.
    Cloughesy, Timothy
    Lai, Albert
    NEURO-ONCOLOGY, 2017, 19 (03) : 394 - 404
  • [39] Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma
    Lu, Yiping
    Patel, Markand
    Natarajan, Kal
    Ughratdar, Ismail
    Sanghera, Paul
    Jena, Raj
    Watts, Colin
    Sawlani, Vijay
    MAGNETIC RESONANCE IMAGING, 2020, 74 : 161 - 170
  • [40] IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas
    Kramar, F.
    Minarik, M.
    Benesova, L.
    Halkova, T.
    Netuka, D.
    Bradac, O.
    Benes, V.
    FOLIA BIOLOGICA, 2016, 62 (05) : 194 - 202
12345